Fortrea holdings inc FTRE.US Overview Analysis
)FTRE AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
With insufficient quarterly financial data released by the company, we're unable to provide a rating.
FTRE Current Performance
5.68%
Fortrea holdings inc
1.31%
Avg of Sector
0.58%
S&P500
Top 10 High Relevance to FTRE
- CRL Charles river laboratories international incValue 4Trend 3Swing Trading 5Whale Interest 3Dividend 1See more
FTRE Profile
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.